2008

More Nomograms or Better Evidence of Efficacy: What Do We Need in Urologic Oncology? 
Catto JWF 
Rebuttal from Authors re: James W.F. Catto. More Nomograms or Better Evidence of Efficacy: What Do We Need in Urologic Oncology? Eur Urol 2008;54:11–12 
Shariat SF, Margulis V, Karakiewicz PI 

The above editorials are based on the following article:
Nomograms for Bladder Cancer 
Shariat SF, Margulis V, Lotan Y et al

Consensus Statement on Natural Orifice Transluminal Endoscopic Surgery and Single-Incision Laparoscopic Surgery: Heralding a New Era in Urology? 
Gettman M, Box G, Averch T et al

Considerations on the Use of Urine Markers for Bladder Cancer 
van Rhijn BWG
Based on:
Urinary Markers in Bladder Cancer 
Vrooman OPJ, Witjes JA

Sickness and Survival in Bladder Cancer: Is Comorbidity the Crystal Ball?
Konety BR
Based on:
Prognostic Impact of Comorbidity in Patients with Bladder Cancer
Megwalu, Vlahiotis, Radwan et al.

Red Wine, Sex, and a Genius 
Bartoletti R,  Mondaini N, Cai T

Prostate-Sparing Cystectomy: Two Sides of the Moon
Muto G
Based on:
Risk Assessment of Prostatic Pathology in Patients Undergoing Radical Cystoprostatectomy
Pettus JA, Al-Ahmadie H, Barocas DA et al.

2007

Should We Abandon the FISH Test? 
Nieder AM, Soloway MS, Herr HW 

When and How to Treat Superficial and Muscle-Invasive Bladder Cancer 
Zlotta A